Advanced Therapies Manufacturing Strategy Digital

Assess the current manufacturing landscape in the context of the COVID-19 pandemic. What are the short and long term implications for advanced therapeutics development?

July 14 - 15, 2020 | Virtual Event

View Program

Vendor Registration

Free End User Registration

Kelvin H. Lee

Institute Director National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Kelvin H. Lee is Director of NIIMBL - the National Institute for Innovation in Manufacturing Biopharmaceuticals and is also Gore Professor of Chemical and Biomolecular Engineering at the University of Delaware. He received a BSE in Chemical Engineering from Princeton and PhD in Chemical Engineering from Caltech. He spent several years in the Biotechnology Institute at the ETH in Zurich, Switzerland and also completed a postdoc in Caltech's Biology Division.

Check out the incredible speaker line-up to see who will be joining Kelvin H..

Download The Latest Agenda

In Partnership With :

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com

Advanced Therapies Manufacturing Strategy Digital Assess the current manufacturing landscape in the context of the COVID-19 pandemic. What are the short and long term implications for advanced therapeutics development?

Kelvin H. Lee

In Partnership With :

Advanced Therapies Manufacturing Strategy Digital

Assess the current manufacturing landscape in the context of the COVID-19 pandemic. What are the short and long term implications for advanced therapeutics development?